Leukemia, Myeloid, Acute
Showing NaN - NaN of 34
Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine 20 mg/m^2, Talacotuzumab 9 mg/kg)
Completed
- Leukemia, Myeloid, Acute
- Decitabine 20 mg/m^2
- Talacotuzumab 9 mg/kg
-
Orange, California
- +80 more
Mar 11, 2019
Leukemia, Myeloid, Acute, MDS Trial in United Kingdom, United States (CC-486)
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
New York, New York
- +4 more
Oct 22, 2018
Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)
Terminated
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Phoenix, Arizona
- +5 more
Oct 17, 2018
Leukemia, Myeloid, Acute Trial in United States (BI 836858)
Completed
- Leukemia, Myeloid, Acute
- BI 836858
-
Chicago, Illinois
- +4 more
May 22, 2018
Leukemia, Myeloid, Acute Trial in Australia, United States (CSL362)
Completed
- Leukemia, Myeloid, Acute
- CSL362
-
Chicago, Illinois
- +4 more
Oct 8, 2015
Leukemia, Myeloid, Acute Trial in United States (Troxatylâ„¢ (troxacitabine))
Terminated
- Leukemia, Myeloid, Acute
- Troxatylâ„¢ (troxacitabine)
-
LaJolla, California
- +19 more
Nov 1, 2006